Literature DB >> 9407386

Correlation of patient immune responses with genetically characterized small round-structured viruses involved in outbreaks of nonbacterial acute gastroenteritis in the United States, 1990 to 1995.

J S Noel1, T Ando, J P Leite, K Y Green, K E Dingle, M K Estes, Y Seto, S S Monroe, R I Glass.   

Abstract

Small round-structured viruses (SRSVs) are a genetically and antigenically diverse group of caliciviruses that are the most common cause of outbreaks of acute nonbacterial gastroenteritis. We have applied both molecular techniques to characterize SRSVs in fecal specimens and serologic assays using four different expressed SRSV antigens to examine the distribution of outbreak strains in the United States and determine if the immune responses of patients were strain specific. Strains from 23 outbreaks of SRSV gastroenteritis were characterized by reverse transcription-PCR and nucleotide sequencing of a 277-base region of the capsid gene. These strains segregated into two distinct genogroups, I and II, comprising four and six clusters of strains respectively, each representing a distinct phylogenetic lineage. Serum IgG responses in patients were measured by enzyme immunoassay using expressed capsid antigens of Norwalk virus (NV), Toronto virus (TV), Hawaii virus (HV), and Lordsdale virus (LV), representing four of the 10 clusters. While strains in genogroups I and II were antigenically distinct, within genogroups, the specificity of the immune response varied greatly. Patients infected with genogroup I strains which had as much as 38.5% aa divergence from NV demonstrated relatively homologous seroresponses to the single NV antigen. In contrast, in genogroup II, homologous seroresponses to TV and HV were only present when the infecting strains showed less than 6.5% aa divergence from these antigens. These results suggest that TV and HV represent not only separate genetic clusters in genogroup II but also separate antigenic groups, each of which is related but distinguishable. In addition, two genetically distinct SRSV strains were identified for which we have no homologous antigen. This study suggests that while current molecular diagnostics are capable of detecting the full range of SRSVs, additional expressed antigens will be required to detect an immune response to SRSV infection caused by all the antigenically diverse strains.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9407386     DOI: 10.1002/(sici)1096-9071(199712)53:4<372::aid-jmv10>3.0.co;2-h

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  60 in total

1.  Capsid protein diversity among Norwalk-like viruses.

Authors:  J Green; J Vinje; C I Gallimore; M Koopmans; A Hale; D W Brown; J C Clegg; J Chamberlain
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

2.  Molecular cloning, expression, and antigenicity of Seto virus belonging to genogroup I Norwalk-like viruses.

Authors:  S Kobayashi; K Sakae; Y Suzuki; K Shinozaki; M Okada; H Ishiko; K Kamata; K Suzuki; K Natori; T Miyamura; N Takeda
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

3.  Broadly reactive and highly sensitive assay for Norwalk-like viruses based on real-time quantitative reverse transcription-PCR.

Authors:  Tsutomu Kageyama; Shigeyuki Kojima; Michiyo Shinohara; Kazue Uchida; Shuetsu Fukushi; Fuminori B Hoshino; Naokazu Takeda; Kazuhiko Katayama
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

4.  International collaborative study to compare reverse transcriptase PCR assays for detection and genotyping of noroviruses.

Authors:  Jan Vinjé; Harry Vennema; Leena Maunula; Carl-Henrik von Bonsdorff; Marina Hoehne; Eckart Schreier; Alison Richards; Jon Green; David Brown; Suzanne S Beard; Stephan S Monroe; Erwin de Bruin; Lennart Svensson; Marion P G Koopmans
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

5.  Asymptomatic and symptomatic excretion of noroviruses during a hospital outbreak of gastroenteritis.

Authors:  Chris I Gallimore; David Cubitt; Nelita du Plessis; Jim J Gray
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

6.  Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity.

Authors:  Sugoto Chakravarty; Anne M Hutson; Mary K Estes; B V Venkataram Prasad
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

7.  Rapid and sensitive detection of noroviruses by using TaqMan-based one-step reverse transcription-PCR assays and application to naturally contaminated shellfish samples.

Authors:  Narayanan Jothikumar; James A Lowther; Kathleen Henshilwood; David N Lees; Vincent R Hill; Jan Vinjé
Journal:  Appl Environ Microbiol       Date:  2005-04       Impact factor: 4.792

8.  Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge.

Authors:  Anna D LoBue; Joseph M Thompson; Lisa Lindesmith; Robert E Johnston; Ralph S Baric
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

9.  Heterotypic humoral and cellular immune responses following Norwalk virus infection.

Authors:  Lisa C Lindesmith; Eric Donaldson; Juan Leon; Christine L Moe; Jeffrey A Frelinger; Robert E Johnston; David J Weber; Ralph S Baric
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

10.  Herd immunity to GII.4 noroviruses is supported by outbreak patient sera.

Authors:  Jennifer L Cannon; Lisa C Lindesmith; Eric F Donaldson; Lauryn Saxe; Ralph S Baric; Jan Vinjé
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.